UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis

Journal of hematology and oncology, 2018-06, Vol.11 (1), p.76-76, Article 76

2018

Volltextzugriff (PDF)

The Clinical and Molecular Profile of Lung Cancer Patients Harboring the TP53 R337H Germline Variant in a Brazilian Cancer Center: The Possible Mechanism of Carcinogenesis

International journal of molecular sciences, 2023-10, Vol.24 (20), p.15035

2023

Volltextzugriff (PDF)

Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds

Oncoimmunology, 2020-01, Vol.9 (1), p.1710052-1710052

2020

Volltextzugriff (PDF)

Interplay between Tumor Mutational Burden and Mutational Profile and Its Effect on Overall Survival: A Pilot Study of Metastatic Patients Treated with Immune Checkpoint Inhibitors

Cancers, 2022-11, Vol.14 (21), p.5433

2022

Volltextzugriff (PDF)

Choice of 16S Ribosomal RNA Primers Impacts Male Urinary Microbiota Profiling

Frontiers in cellular and infection microbiology, 2022-04, Vol.12, p.862338-862338

2022

Volltextzugriff (PDF)

Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology

Integrative cancer therapies, 2018-12, Vol.17 (4), p.1012-1015

2018

Volltextzugriff (PDF)

Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer

Frontiers in oncology, 2019-03, Vol.9, p.170

2019

Volltextzugriff (PDF)

Noninvasive cancer biomarkers in solid malignancies: circulating tumor DNA-clinical utility, current limitations and future perspectives

Annals of translational medicine, 2018-06, Vol.6 (11), p.233-233

2018

Volltextzugriff (PDF)

Trametinib and Hydroxychloroquine (HCQ) Combination Treatment in KRAS-Mutated Advanced Pancreatic Adenocarcinoma: Detailed Description of Two Cases

Journal of gastrointestinal cancer, 2021-03, Vol.52 (1), p.374-380

2021

Volltextzugriff (PDF)

Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics

The oncologist (Dayton, Ohio), 2021-04, Vol.26 (4), p.e715-e718

2021

Volltextzugriff (PDF)

SARS-CoV-2 testing for asymptomatic adult cancer patients before initiating systemic treatments: a systematic review

Ecancermedicalscience, 2020-09, Vol.14, p.1100-1100

2020

Volltextzugriff (PDF)

Recent results of immunotherapy and perspectives for advanced NSCLC

Lung cancer management, 2016-06, Vol.5 (2), p.57-60

2016

Volltextzugriff (PDF)

MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors

Oncoscience, 2014, Vol.1 (1), p.5-13

2014

Volltextzugriff (PDF)

Cardiovascular and thromboembolic events associated with intense neoadjuvant androgen deprivation therapy followed by prostatectomy in patients with localized prostate cancer: A meta-analysis of clinical trials

Journal of clinical oncology, 2023-02, Vol.41 (6_suppl), p.341-341

2023

Volltextzugriff (PDF)

Association between tumor mutational burden (TMB) and mutational profile and its effect on overall survival: A post hoc analysis of patients with TMB-high and TMB-low metastatic cancer treated with immune checkpoint inhibitors (ICI)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.2632-2632

2022

Volltextzugriff (PDF)

Impact of COVID-19 pandemic on the treatment of prostate cancer in the Brazilian public health system

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17106-e17106

2023

Volltextzugriff (PDF)

The Clinical and Molecular Profile of Lung Cancer Patients Harboring the ITP53/I R337H Germline Variant in a Brazilian Cancer Center: The Possible Mechanism of Carcinogenesis

International journal of molecular sciences, 2023-10, Vol.24 (20)

2023

Volltextzugriff (PDF)

Response

JNCI : Journal of the National Cancer Institute, 2016-03, Vol.108 (3), p.djw001

2016

Volltextzugriff (PDF)

Use of expansion cohorts in phase 1 trials and probability of success in phase 2 for 381 anticancer drugs

Clinical cancer research, 2017-04, Vol.23 (15), p.4020-4026

2017

Volltextzugriff (PDF)

Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of high-risk clear cell renal carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase inhibitors (VEGFR TKIs)

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.660-660

2018

Volltextzugriff (PDF)

Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of renal cell carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase inhibitors (VEGFR TKIs)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4579-4579

2019

Volltextzugriff (PDF)

Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval

JNCI : Journal of the National Cancer Institute, 2015-11, Vol.107 (11), p.1

2015

Volltextzugriff (PDF)

Response

JNCI : Journal of the National Cancer Institute, 2016-03, Vol.108 (3), p.djw001-djw001

2016

Volltextzugriff (PDF)

Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer

Frontiers in oncology, 2019, Vol.9, p.170-170

2019

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(26)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MET alterations detected in blood-derived circulating tumor DNA correlate with bone metastases and poor prognosis

The Clinical and Molecular Profile of Lung Cancer Patients Harboring the TP53 R337H Germline Variant in a Brazilian Cancer Center: The Possible Mechanism of Carcinogenesis

Efficacy and safety of anticancer drug combinations: a meta-analysis of randomized trials with a focus on immunotherapeutics and gene-targeted compounds

Interplay between Tumor Mutational Burden and Mutational Profile and Its Effect on Overall Survival: A Pilot Study of Metastatic Patients Treated with Immune Checkpoint Inhibitors

Choice of 16S Ribosomal RNA Primers Impacts Male Urinary Microbiota Profiling

Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology

Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer

Noninvasive cancer biomarkers in solid malignancies: circulating tumor DNA-clinical utility, current limitations and future perspectives

Trametinib and Hydroxychloroquine (HCQ) Combination Treatment in KRAS-Mutated Advanced Pancreatic Adenocarcinoma: Detailed Description of Two Cases

Landscape of Cyclin Pathway Genomic Alterations Across 5,356 Prostate Cancers: Implications for Targeted Therapeutics

SARS-CoV-2 testing for asymptomatic adult cancer patients before initiating systemic treatments: a systematic review

Recent results of immunotherapy and perspectives for advanced NSCLC

MET nucleotide variations and amplification in advanced ovarian cancer: characteristics and outcomes with c-Met inhibitors

Cardiovascular and thromboembolic events associated with intense neoadjuvant androgen deprivation therapy followed by prostatectomy in patients with localized prostate cancer: A meta-analysis of clinical trials

Association between tumor mutational burden (TMB) and mutational profile and its effect on overall survival: A post hoc analysis of patients with TMB-high and TMB-low metastatic cancer treated with immune checkpoint inhibitors (ICI)

Impact of COVID-19 pandemic on the treatment of prostate cancer in the Brazilian public health system

The Clinical and Molecular Profile of Lung Cancer Patients Harboring the ITP53/I R337H Germline Variant in a Brazilian Cancer Center: The Possible Mechanism of Carcinogenesis

Response

Use of expansion cohorts in phase 1 trials and probability of success in phase 2 for 381 anticancer drugs

Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of high-risk clear cell renal carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase inhibitors (VEGFR TKIs)

Meta-analysis of randomized clinical trials (RCT) for the adjuvant treatment of renal cell carcinoma (RCC) with vascular endothelial growth factor receptor tyrosine-kinase inhibitors (VEGFR TKIs)

Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-Analysis of Clinical Trials Leading to FDA Approval

Genomic Biomarkers and Underlying Mechanism of Benefit from BCG Immunotherapy in Non-Muscle Invasive Bladder Cancer

Response

Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer

Aktive Filter

Suchergebnisse filtern